NEXGEL, Inc. (NXGL)

USD 4.23

(-10.19%)

EBITDA Summary of NEXGEL, Inc.

  • NEXGEL, Inc.'s latest annual EBITDA in 2023 was -2.73 Million USD , up 0.33% from previous year.
  • NEXGEL, Inc.'s latest quarterly EBITDA in 2024 Q2 was -968 Thousand USD , down -11.21% from previous quarter.
  • NEXGEL, Inc. reported an annual EBITDA of -3.1 Million USD in 2022, down -23.89% from previous year.
  • NEXGEL, Inc. reported an annual EBITDA of -2.19 Million USD in 2021, down -11.58% from previous year.
  • NEXGEL, Inc. reported a quarterly EBITDA of -968 Thousand USD for 2024 Q2, down -11.21% from previous quarter.
  • NEXGEL, Inc. reported a quarterly EBITDA of -848 Thousand USD for 2023 Q1, down -50.62% from previous quarter.

Annual EBITDA Chart of NEXGEL, Inc. (2023 - 2016)

Historical Annual EBITDA of NEXGEL, Inc. (2023 - 2016)

Year EBITDA EBITDA Growth
2023 -2.73 Million USD 0.33%
2022 -3.1 Million USD -23.89%
2021 -2.19 Million USD -11.58%
2020 -2.2 Million USD -18.58%
2019 -1.85 Million USD -18.58%
2018 -1.56 Million USD -139.82%
2017 -653 Thousand USD 57.6%
2016 -1.54 Million USD 0.0%

Peer EBITDA Comparison of NEXGEL, Inc.

Name EBITDA EBITDA Difference
Akoya Biosciences, Inc. -45.63 Million USD 94.017%
AngioDynamics, Inc. -14.29 Million USD 80.898%
AtriCure, Inc. -8.1 Million USD 66.334%
Avinger, Inc. -16.34 Million USD 83.299%
Azenta, Inc. 55.15 Million USD 104.95%
BioLife Solutions, Inc. -45.23 Million USD 93.965%
The Cooper Companies, Inc. 882.8 Million USD 100.309%
Daxor Corporation 329.74 Thousand USD 927.925%
Ekso Bionics Holdings, Inc. -13.19 Million USD 79.315%
Femasys Inc. -13.16 Million USD 79.27%
GlucoTrack, Inc. -7.09 Million USD 61.5%
Harvard Bioscience, Inc. 9.49 Million USD 128.758%
Hologic, Inc. 1.29 Billion USD 100.211%
ICU Medical, Inc. 307.69 Million USD 100.887%
Intuitive Surgical, Inc. 2.39 Billion USD 100.114%
KORU Medical Systems, Inc. -9.39 Million USD 70.956%
LeMaitre Vascular, Inc. 48.99 Million USD 105.573%
Innovative Eyewear, Inc. -6.57 Million USD 58.48%
Innovative Eyewear, Inc. -6.57 Million USD 58.48%
Masimo Corporation 236.7 Million USD 101.153%
Microbot Medical Inc. -10.63 Million USD 74.328%
Meihua International Medical Technologies Co., Ltd. 15.77 Million USD 117.311%
Merit Medical Systems, Inc. 231.44 Million USD 101.18%
Nephros, Inc. -1.37 Million USD -97.97%
NovoCure Limited -175.86 Million USD 98.448%
NEXGEL, Inc. -2.73 Million USD -0.0%
Singular Genomics Systems, Inc. -86.49 Million USD 96.844%
OraSure Technologies, Inc. 76.15 Million USD 103.585%
Pro-Dex, Inc. 8.33 Million USD 132.761%
Pulse Biosciences, Inc. -42.36 Million USD 93.556%
Predictive Oncology Inc. -13.18 Million USD 79.29%
Precision Optics Corporation, Inc. -2.51 Million USD -8.68%
QuidelOrtho Corporation 545.6 Million USD 100.5%
Repligen Corporation 124.29 Million USD 102.196%
Sanara MedTech Inc. -289.09 Thousand USD -844.32%
STAAR Surgical Company 33.22 Million USD 108.218%
Sharps Technology, Inc. -8.98 Million USD 69.6%
Utah Medical Products, Inc. 24.8 Million USD 111.006%
DENTSPLY SIRONA Inc. 232 Million USD 101.177%
Jin Medical International Ltd. 3.44 Million USD 179.294%